Agios Pharmaceuticals | AGIO - 净收入



金融业
股票价格
USD
资产
USD 1.18B
现金及等价物
USD 113.6M
销售成本
USD 1.32M
流动资产
USD 834.84M
流动负债
USD 58.85M
债务
USD 40.21M
EBIT
USD -110.03M
EBITDA
USD -120.31M
员工
486
EPS每股收益
USD -1.69
股本和储备
USD 1.11B
销售毛利
USD 19.43M
债务利息支出
USD 1.18B
利息收入
USD 12.41M
贷款资金
USD 1.06M
市值
USD 1.65B
净收入
USD -99.11M
营业费用
USD 130.77M
营业利润
USD -110.03M
普通股股本
USD 59.34M
PE价格收益
3.56
税前利润
USD -99.11M
销售收入
USD 18.8M
销售和管理费用
USD 38.46M
股票
USD 35.09M
贸易债权人
USD 13.75M
应收帐款人
USD 16.13M


净收入 更改 日
AbbVie USD 695M 1.12B 2026-03
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
Arrowhead Research USD -132.73M 163.54M 2026-03
Astellas Pharma JPY 43.52B 56.86B 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Exelixis USD 210.47M 34.06M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Incyte USD 303.33M 4.05M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Merck USD -4.24B 7.2B 2026-03
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD 2.69B 4.34B 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03